1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Proteinuria: new trials by email Literature Review of Proteinuria trials Research Report on Proteinuria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Resveratrol's Effects in Diabetic Nephropathy Resveratrol, Placebo, Losartan - Diabetic Nephropathy | Early Phase 1 | Completed | Shiraz University of Medical Sciences | 60 | 2016-03-01 | 2017-10-05 |
| Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes Amiloride, HCTZ - Proteinuria, Hypertension | Early Phase 1 | Terminated | University of New Mexico | 9 | 2013-03-01 | 2018-05-11 |
Albuminuria (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Hypertension (1) · Renal Insufficiency (1)
Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glucose Metabolism Disorders (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urination Disorders (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2) · Cardiovascular Diseases (1) · Diabetes Mellitus (1)
Amiloride (1) · Hydrochlorothiazide (1) · Losartan (1) · Resveratrol (1)
Shiraz University of Medical Sciences (1) · University of New Mexico (1)
Iran (1) · United States (1)
Azar Sattarinejad, MD (1) · Gholamhossein Ranjbar Omrani, MD (1) · Jamshid Roozbeh, MD (1) · Mark L Unruh, MD MSc (1) · Mesbah Shams, MD (1)